Antiphospholipid antibodies, antiphospholipid syndrome and infections.

[1]  R. Cervera,et al.  Catastrophic antiphospholipid (Asherson's) syndrome. , 2006, British journal of hospital medicine.

[2]  Y. Shoenfeld,et al.  The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. , 2005, Immunobiology.

[3]  Y. Shoenfeld,et al.  Infectious origin of the antiphospholipid syndrome , 2005, Annals of the rheumatic diseases.

[4]  H. Laurichesse,et al.  Infections associées à des évènements thrombotiques sévères avec présence d'anticorps antiphospholipides , 2005 .

[5]  S. Senanayake,et al.  Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  M. García-Carrasco,et al.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients , 2004, Annals of the rheumatic diseases.

[7]  Z. Al-Kadhimi,et al.  HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. , 2004, AIDS patient care and STDs.

[8]  M. García-Carrasco,et al.  Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Asherson,et al.  Anticardiolipin, anti-β2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease , 2003, Annals of the rheumatic diseases.

[10]  C. Mavrogiannis,et al.  Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B‐related hepatocellular carcinoma. Relationship with portal vein thrombosis , 2003, European journal of gastroenterology & hepatology.

[11]  Y. Shoenfeld,et al.  Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines , 2003, Lupus.

[12]  E. Tsianos,et al.  Anti‐cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2‐glycoprotein I cofactor or features of antiphospholipid syndrome , 2003, European journal of clinical investigation.

[13]  P. Youinou,et al.  Distinguishing Features of Anti-β2 Glycoprotein I Antibodies between Patients with Leprosy and the Antiphospholipid Syndrome , 2002, Thrombosis and Haemostasis.

[14]  J. Piette,et al.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. , 2002, Arthritis and rheumatism.

[15]  M. Petri,et al.  Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients , 2001, Medicine.

[16]  A. Ko,et al.  Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. , 2001, Clinical and experimental rheumatology.

[17]  E. Fernández,et al.  Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections , 2001, Annals of the rheumatic diseases.

[18]  Y. Lurie,et al.  Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection , 2000, Annals of the rheumatic diseases.

[19]  S. Sauleda,et al.  Anticardiolipin Antibodies in Patients with Chronic Hepatitis C Virus Infection: Characterization in Relation to Antiphospholipid Syndrome , 2000, Clinical Diagnostic Laboratory Immunology.

[20]  P. Voulgari,et al.  Increased incidence of anti‐cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti‐phospholipid syndrome , 2000, European journal of gastroenterology & hepatology.

[21]  H. Moutsopoulos,et al.  Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. , 1999, Journal of autoimmunity.

[22]  M. Margaglione,et al.  Anticardiolipin antibodies in patients with liver disease , 1999, American Journal of Gastroenterology.

[23]  L. Carreras,et al.  Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. , 1999, Thrombosis research.

[24]  F. Muñoz-Rodríguez,et al.  Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. , 1999, Journal of hepatology.

[25]  A. Gharavi,et al.  Antibodies to cardiolipin and β2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis , 1999, Lupus.

[26]  P. Giordano,et al.  Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia , 1998, British journal of haematology.

[27]  V. Leroy,et al.  Prevalence and significance of anticardiolipin, anti‐β2 glycoprotein I and anti‐prothrombin antibodies in chronic hepatitis C , 1998 .

[28]  C. Biron,et al.  Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. , 1998, The Journal of laboratory and clinical medicine.

[29]  Z. Amoura,et al.  Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group. , 1997, The Journal of rheumatology.

[30]  W. Rozenbaum,et al.  Autoantibodies to Phospholipids and to the Coagulation Proteins in AIDS , 1997, Thrombosis and Haemostasis.

[31]  G. Acuña,et al.  Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  E. Gratacós,et al.  Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection , 1995, Prenatal Diagnosis.

[33]  Y. Shoenfeld,et al.  Anticardiolipin Antibodies in Infections are Heterogenous in Their Dependency on β 2-Glycoprotein I: Analysis of Anticardiolipin Antibodies in Leprosy , 1994, Lupus.

[34]  F. Johnstone,et al.  Anticardiolipin antibodies and pregnancy outcome in women with human immunodeficiency virus infection , 1992, Obstetrics and gynecology.

[35]  H. Yazbeck,et al.  Anticardiolipin antibodies and acquired immunodeficiency syndrome: Prognostic marker or association with HIV infection? , 1992, Infection.

[36]  Hunt,et al.  A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection , 1992, Lupus.

[37]  G. Hughes,et al.  The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.

[38]  G. Hughes,et al.  The anticardiolipin syndrome. , 1985, The Journal of rheumatology.

[39]  I. Palomo,et al.  Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)‐infected Chilean patients , 2003, Journal of clinical laboratory analysis.

[40]  S. Malnick,et al.  HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy. , 1997, Journal of clinical gastroenterology.